Professor and Chief, Section of Surgical Oncology, Louisiana State University, Department of Surgery School of Medicine, New Orleans, LA
General Surgery
Dr. Adam I. Riker, MD
|
|
Give Review
Adam I. Riker, MD works in the field of General Surgery. He studied medicine at University of South Florida College of Medicine. University of South Florida College of Medicine is ranked 79 in research and 85 in primary care medicine He received 1 awards: "Fellow (FACS)". Dr. Adam I. Riker is a published doctor. He has 69 papers published. The most current publication "Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Radiotherapy for breast Cancer, the TARGIT-A trial.
- Up-regulation of miR-182 expression after epigenetic modulation of human Melanoma cells.
- Aquaporins mediate the chemoresistance of human Melanoma cells to arsenite.
- Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared with Non-Melanoma Skin Cancer.
- Overexpression of the progestagen-associated endometrial protein gene is associated with microphthalmia-associated transcription factor in human Melanoma.
- Emerging metabolic targets in Cancer therapy.
- MicroRNA-125b confers the resistance of breast Cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
- The epidemiology, prevention, and detection of Melanoma.
- MicroRNA in Melanoma.
- The hedgehog pathway transcription factor GLI1 promotes malignant behavior of Cancer cells by up-regulating osteopontin.
- Epigenetics in human Melanoma.
- Current concepts in biobanking: development and implementation of a Tissue repository.
- Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic Melanoma.
- Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk Melanoma treated with adjuvant granulocyte macrophage colony-stim...
- Activated stat-3 in Melanoma.
- The impact of genomics in understanding human Melanoma progression and metastasis.
- Full-thickness grafts procured from Skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
- Significance of sentinel lymph node micrometastases in human breast Cancer.
- Down-regulation of pro-apoptotic genes is an early event in the progression of malignant Melanoma.
- Roscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic Melanoma.
- Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine Melanoma model.
- Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
- Immunotherapy as part of a multidisciplinary approach to Melanoma treatment.
- Sentinel node biopsy for thin Melanomas: which patients should be considered?
- Isolation and culture of Melanoma cell lines.
- Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.
- Interferon-gamma reduces melanosomal antigen expression and recognition of Melanoma cells by cytotoxic T cells.
- Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopy.
- Advances in the early detection, diagnosis, and staging of pancreatic Cancer.
- Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.
- Comment on Rahusen et al.
- Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.
- Pancreaticoduodenectomy for chronic pancreatitis: a case report and literature review.
- InDuction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells.
- Association of insulin-like growth factor binding protein-3 expression with Melanoma progression.
- Immune selection after antigen-specific immunotherapy of Melanoma.
- Global comparative gene expression analysis of Melanoma patient samples, derived cell lines and corresponding tumor xenografts.
- A tumor-infiltrating lymphocyte from a Melanoma metastasis with decreased expression of Melanoma differentiation antigens recognizes MAGE-12.
- Expansion of tumor-T cell pairs from fine needle aspirates of Melanoma metastases.
- Utility of fine-needle aspiration biopsy for prospective analysis of patients undergoing therapy for metastatic Melanoma.
- Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in Peripheral blood mononuclear cells and tumor specimens.
- Development and characterization of Melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic Melanoma.
- Functional dissociation between local and systemic immune response during anti-Melanoma peptide vaccination.
- Evidence of gender bias in patients undergoing flexible sigmoidoscopy.
- Vascular complications after femoral artery catheterization in burn patients.
- Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant Melanoma participating in immunotherapy clinical trials: a p...
- Short-term kinetics of tumor antigen expression in response to vaccination.
- Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant Melanoma.
- Threshold levels of gene expression of the Melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.
- Management of tracheobronchial strictures and fistulas: a report and review of literature.
- Cutaneous Melanoma: methods of biopsy and definitive surgical excision.
- Current surgical management of Melanoma.
- Comparative methodologies of regulatory T cell depletion in a murine Melanoma model.
- Immunotherapy of Melanoma: a critical review of current concepts and future strategies.
- The gene expression profiles of primary and metastatic Melanoma yields a transition point of tumor progression and metastasis.
- Successful removal of a giant intrathoracic lipoma: a case report and review of the literature.
- Identification of novel epigenetically modified genes in human Melanoma via promoter methylation gene profiling.
- Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast Cancer metastasis suppressor 1.
- Mitf-Mdel, a novel melanocyte/Melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for Melanoma.
- Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant Cancer cells to taxol.
- Cystatin E/M suppresses legumain activity and invasion of human Melanoma.
- A personalized microRNA microarray normalization method using a logistic regression model.
- Functional characterization of the progestagen-associated endometrial protein gene in human Melanoma.
- The 14-3-3sigma gene promoter is methylated in both human melanocytes and Melanoma.
- Carcinosarcoma of the Breast: two case reports and review of the literature.
- Expression and functional analysis of the WAP four disulfide core domain 1 gene in human Melanoma.
- Expression of gp100 and CDK2 in Melanoma cells is not co-regulated by a shared promoter region.
- Use of ipilimumab in Melanoma.
Schools
University Of South Florida College Of Medicine
Loyola University Medical Center
University Of South Florida
National Cancer Institute
Procedures Preformed
- Biopsy
- Biopsy of Breast
- Brachytherapy
- Breast Surgical Procedure
- View All
Conditions Treated
- Bile Duct Cancer
- Breast Cancer
- Breast Diseases
- Breast Lump
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care of Illinois PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- HealthLink PPO
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Pipefitters
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
- Fellow (FACS)
Education
-
Loyola University -
University of South Florida College of Medicine
Drug Facts
| NPI NUMBER | 1194773069 | |
| NPPES Provider LastName | RIKER | |
| NPPES Provider FirstName | ADAM | |
| NPPES Provider ZIPCode | 60453 | |
| NPPES Provider State | IL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194773069 |
| Last Name Of The Provider | RIKER |
| First Name Of The Provider | ADAM |
| View All |
Similar Doctors
|
Dr. Jennifer L. Gambla, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kanesha L. Bryant, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William M. Hopkins, MD |
|
Dr. Rodney H. Thill, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Patrice R. Frederick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Felipe Gracias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan M. Roman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. George F. Mesleh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Bernard P. Flaherty
This Doctor is OpenDoctor Recommended.
|